FACIT
FACIT is a commercialization venture firm that builds companies with entrepreneurs to accelerate oncology innovation, with a portfolio that has attracted over $850 million in investment to Ontario. Blending industry experience, capital and the unsurpassed clinician-scientist network of its strategic partner the Ontario Institute for Cancer Research (OICR), FACIT capitalizes on the province's investment in research and healthcare to the benefit of the local economy and patients worldwide.
FACIT
Founded:
2012-01-01
Status:
Active
Contact:
+1-647-260-7989
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default WordPress Apache Wordpress Plugins Mobile Non Scaleable Content Nginx Sitelinks Search Box Euro
Similar Organizations
FIRST
FIRST aims to inspire young people to be science and technology leaders.
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2021-05-17 | QurCan Therapeutics Inc. | FACIT investment in Seed Round - QurCan Therapeutics Inc. | 3 M USD |
2020-06-24 | Replica Analytics | FACIT investment in Seed Round - Replica Analytics | 1000 K USD |
2020-02-05 | bridge7 | FACIT investment in Seed Round - bridge7 | N/A |
2020-01-28 | Xpan | FACIT investment in Seed Round - Xpan | N/A |
2020-01-28 | QurCan Therapeutics Inc. | FACIT investment in Seed Round - QurCan Therapeutics Inc. | N/A |
2019-10-30 | Cellular Analytics | FACIT investment in Seed Round - Cellular Analytics | N/A |
2019-04-09 | QurCan Therapeutics Inc. | FACIT investment in Seed Round - QurCan Therapeutics Inc. | N/A |
2019-04-02 | Fusion Pharmaceuticals | FACIT investment in Series B - Fusion Pharmaceuticals | 105 M USD |
2019-01-10 | DNAstack | FACIT investment in Pre Seed Round - DNAstack | N/A |
2018-09-13 | Talon Pharmaceuticals | FACIT investment in Venture Round - Talon Pharmaceuticals | N/A |